Profitability at all-time highs - Marksans Pharma Ltd

Code BSE: 524404 NSE:

Marksans Pharma delivers record Q1FY27 — Profitability at all-time highs, cash crosses Rs 1,000 crore Q1FY27 Financial Highlights a) Operating Revenue stood at Rs. 841 cr., up by 35.6% YoY b) Gross profit came in at Rs. 497 cr., up by 38.9% YoY, with a gross margin of 59.1% c) EBITDA stood at Rs. 213 cr., up by 112.8% YoY, with an EBITDA margin of 25.3% d) PAT stood at Rs. 159 cr., up by 173.9% YoY, with a net margin of 18.4% e) EPS was at Rs. 3.5